BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 35770721)

  • 1. State-of-the-art review on the correlations between pathological and magnetic resonance features of cirrhotic nodules.
    Renzulli M; Braccischi L; D'Errico A; Pecorelli A; Brandi N; Golfieri R; Albertini E; Vasuri F
    Histol Histopathol; 2022 Dec; 37(12):1151-1165. PubMed ID: 35770721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation.
    Earls JP; Theise ND; Weinreb JC; DeCorato DR; Krinsky GA; Rofsky NM; Mizrachi H; Teperman LW
    Radiology; 1996 Oct; 201(1):207-14. PubMed ID: 8816545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR characterisation of dysplastic nodules and hepatocarcinoma in the cirrhotic liver with hepatospecific superparamagnetic contrast agents: pathological correlation in explanted livers.
    Macarini L; Milillo P; Cascavilla A; Scalzo G; Stoppino L; Vinci R; Moretti G; Ettorre G
    Radiol Med; 2009 Dec; 114(8):1267-82. PubMed ID: 19902328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance of focal liver lesions in hepatic cirrhosis and chronic hepatitis.
    Martín J; Puig J; Darnell A; Donoso L
    Semin Ultrasound CT MR; 2002 Feb; 23(1):62-78. PubMed ID: 11866223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma.
    Kim MJ; Lee S; An C
    Eur Radiol; 2019 Sep; 29(9):5101-5110. PubMed ID: 30788586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm.
    Renzulli M; Biselli M; Brocchi S; Granito A; Vasuri F; Tovoli F; Sessagesimi E; Piscaglia F; D'Errico A; Bolondi L; Golfieri R
    Gut; 2018 Sep; 67(9):1674-1682. PubMed ID: 29437912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal lesions in the cirrhotic liver: their pivotal role in gadoxetic acid-enhanced MRI and recognition by the Western guidelines.
    Golfieri R; Garzillo G; Ascanio S; Renzulli M
    Dig Dis; 2014; 32(6):696-704. PubMed ID: 25376286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic evaluation of hepatocellular carcinoma in a cirrhotic liver.
    Gogel BM; Goldstein RM; Kuhn JA; McCarty TM; Donahoe A; Glastad K
    Oncology (Williston Park); 2000 Jun; 14(6 Suppl 3):15-20. PubMed ID: 10887647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocarcinogenesis in liver cirrhosis: imaging diagnosis.
    Choi BI
    J Korean Med Sci; 1998 Apr; 13(2):103-16. PubMed ID: 9610609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI and pathology aspects of hypervascular nodules in cirrhotic liver: from dysplasia to hepatocarcinoma.
    Gheonea IA; Streba CT; Cristea CG; Stepan AE; Ciurea ME; Sas T; Bondari S
    Rom J Morphol Embryol; 2015; 56(3):925-35. PubMed ID: 26662124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature.
    Peng C; Kaščáková S; Chiappini F; Olaya N; Sandt C; Yousef I; Samuel D; Dumas P; Guettier C; Le Naour F
    J Transl Med; 2016 Jan; 14():9. PubMed ID: 26754490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entity.
    Kudo M
    Intervirology; 2004; 47(3-5):227-37. PubMed ID: 15383732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma (HCC) in non-cirrhotic liver: clinical, radiological and pathological findings.
    Di Martino M; Saba L; Bosco S; Rossi M; Miles KA; Di Miscio R; Lombardo CV; Tamponi E; Piga M; Catalano C
    Eur Radiol; 2014 Jul; 24(7):1446-54. PubMed ID: 24770466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of nodules in liver cirrhosis: spiral computed tomography or magnetic resonance imaging? A prospective study of 88 nodules in 34 patients.
    de Lédinghen V; Laharie D; Lecesne R; Le Bail B; Winnock M; Bernard PH; Saric J; Couzigou P; Balabaud C; Bioulac-Sage P; Drouillard J
    Eur J Gastroenterol Hepatol; 2002 Feb; 14(2):159-65. PubMed ID: 11981340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pearls and pitfalls in magnetic resonance imaging of hepatocellular carcinoma.
    Kovac JD; Milovanovic T; Dugalic V; Dumic I
    World J Gastroenterol; 2020 May; 26(17):2012-2029. PubMed ID: 32536771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular nodules in liver cirrhosis: MR evaluation.
    Lee JM; Choi BI
    Abdom Imaging; 2011 Jun; 36(3):282-9. PubMed ID: 21399975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies.
    Willatt JM; Hussain HK; Adusumilli S; Marrero JA
    Radiology; 2008 May; 247(2):311-30. PubMed ID: 18430871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variant Hepatocellular Carcinoma Subtypes According to the 2019 WHO Classification: An Imaging-Focused Review.
    Loy LM; Low HM; Choi JY; Rhee H; Wong CF; Tan CH
    AJR Am J Roentgenol; 2022 Aug; 219(2):212-223. PubMed ID: 35170359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to detect hepatocellular carcinoma in cirrhosis.
    Ward J; Robinson PJ
    Eur Radiol; 2002 Sep; 12(9):2258-72. PubMed ID: 12195479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing Borderline Hepatic Nodules in Hepatocarcinogenesis: Imaging Performance.
    Choi BI; Lee JM; Kim TK; Dioguardi Burgio M; Vilgrain V
    AJR Am J Roentgenol; 2015 Jul; 205(1):10-21. PubMed ID: 26102378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.